Table 1.
An overview of the cases used in the study, including details of the type, and target of cortical and thalamic tracer injections.
| Cases | Injection sites | Tracer | Immunofluo rescence |
|---|---|---|---|
| Thalamic injections (retrograde tracers) | |||
| 215#4 | MD, PV, CM | CtB | |
| RE/Rh | FB | ||
| 208#9 | RE | FB | |
| 207#2 | RE/Rh (SMT, IAM) | FB | Parvalbumin |
| 207#4 | RE/Rh (CM, IMD) | FB | |
| 207#7 | RE (PVT, CM, IAM) | FB | |
| 209#10 | RE/posterior hypothalamus | CtB | |
| 207#1 | RE | FB | Parvalbumin |
| Cortical injections (retrograde tracers) | |||
| 199#29 | RSC | FB | |
| 225#4 | RSC | CtB | |
| 225#12 | RSC | CtB | |
| 223#1 | RSC | CtB | |
| 198#12 | RSC | FB | |
| 199#29 | RSC | FB | |
| 225#1 | RSC | CtB | Parvalbumin |
| 225#1 | Cg | FB | Parvalbumin |
| 222#10 | RSC | CtB | |
| 222#10 | Cg | FB | |
| 223#5 | Cg | FB | |
| 223#26 | Cg | CtB | |
| FGrsc#1 | RSC | FG | Parvalbumin |
| FGrsc#2 | RSC | FG | Parvalbumin |
| LK#1 | RSC | CtB | Parvalbumin |
| Cortical injections (anterograde tracers) | |||
| 224#30 | RSC | AAV-CaMKIIa-EGFP, AAV5 | |
| 224#29 | RSC | AAV-CaMKIIa-EGFP, AAV5 | |
| 219#2 | Cg | AAV-CaMKIIa-EGFP, AAV5 | |
| 219#9 | Cg | AAV-CaMKIIa-EGFP, AAV5 | |
| 219#3 | Cg | AAV-CaMKIIa-hM4D(Gi)-mCherry, AAV5 | Parvalbumin |
| 219#17 | Cg | AAV-CaMKIIa-hM4D(Gi)-mCherry, AAV5 | |
| 219#21 | Cg | AAV-CaMKIIa-hM4D(Gi)-mCherry, AAV5 | |
| Immunohisto | Marker | Plane | |
| chemistry | |||
| HPCLA1 | Crym, Gng2 | Coronal | |
| HPCLA2 | Crym, Gng2 | Coronal | |
| RCLA1 | Crym, Gng2 | Coronal | |
| RCLA2 | Gng2 | Coronal | |
| RCLA3 | Gng2, Crym | Coronal | |
| RCLA4 | Gng2 | Coronal | |
| RCLA5 | Coronal | ||
| SHPC1 | PV | Coronal | |
| BiFlex1 | PV, Crym | Coronal | |
| BiRCLA1 | PV, Crym | Coronal | |
| BiRCLA2 | PV | Coronal | |
| BiRCLA3 | PV, Crym | Coronal | |
| CLArsc2 | PV | Horizontal (axial) | |
| WK2 | PV | Horizontal (axial) | |
| LH1 | Gng2 | Coronal | |
| LH2 | Gng2 | Coronal | |